Literature DB >> 25661911

Cognition as a target in schizophrenia, bipolar disorder and depression.

Anabel Martinez-Aran1, Eduard Vieta2.   

Abstract

Entities:  

Mesh：

Year:  2015        PMID： 25661911     DOI： 10.1016/j.euroneuro.2015.01.007

Source DB:  PubMed          Journal:  Eur Neuropsychopharmacol        ISSN： 0924-977X            Impact factor:   4.600


× No keyword cloud information.
  17 in total

Review 1.  Cerebellar Cortex as a Therapeutic Target for Neurostimulation.

Authors:  Kim van Dun; Hiroshi Mitoma; Mario Manto
Journal:  Cerebellum       Date:  2018-12       Impact factor: 3.847

Review 2.  Treatment of Functional Impairment in Patients with Bipolar Disorder.

Authors:  Jose Sanchez-Moreno; Anabel Martinez-Aran; Eduard Vieta
Journal:  Curr Psychiatry Rep       Date:  2017-01       Impact factor: 5.285

3.  Functional remediation: the pathway from remission to recovery in bipolar disorder.

Authors:  Eduard Vieta; Carla Torrent
Journal:  World Psychiatry       Date:  2016-10       Impact factor: 49.548

Review 4.  Cognitive Impairment in Patients with Bipolar Disorder: Impact of Pharmacological Treatment.

Authors:  Ni Xu; Benjamin Huggon; Kate E A Saunders
Journal:  CNS Drugs       Date:  2020-01       Impact factor: 5.749

5.  The genome-wide risk alleles for psychiatric disorders at 3p21.1 show convergent effects on mRNA expression, cognitive function, and mushroom dendritic spine.

Authors:  Zhihui Yang; Danyang Zhou; Huijuan Li; Xin Cai; Weipeng Liu; Lu Wang; Hong Chang; Ming Li; Xiao Xiao
Journal:  Mol Psychiatry       Date:  2019-11-13       Impact factor: 15.992

Review 6.  Cognitive dysfunction in bipolar disorder and schizophrenia: a systematic review of meta-analyses.

Authors:  Beatrice Bortolato; Kamilla W Miskowiak; Cristiano A Köhler; Eduard Vieta; André F Carvalho
Journal:  Neuropsychiatr Dis Treat       Date:  2015-12-17       Impact factor: 2.570

7.  Neuropsychological and functional outcomes in recent-onset major depression, bipolar disorder and schizophrenia-spectrum disorders: a longitudinal cohort study.

Authors:  R S C Lee; D F Hermens; S L Naismith; J Lagopoulos; A Jones; J Scott; K M Chitty; D White; R Robillard; E M Scott; I B Hickie
Journal:  Transl Psychiatry       Date:  2015-04-28       Impact factor: 6.222

Review 8.  Innovative approaches to bipolar disorder and its treatment.

Authors:  Paul J Harrison; Andrea Cipriani; Catherine J Harmer; Anna C Nobre; Kate Saunders; Guy M Goodwin; John R Geddes
Journal:  Ann N Y Acad Sci       Date:  2016-02       Impact factor: 5.691

Review 9.  Cognitive remission: a novel objective for the treatment of major depression?

Authors:  Beatrice Bortolato; Kamilla W Miskowiak; Cristiano A Köhler; Michael Maes; Brisa S Fernandes; Michael Berk; André F Carvalho
Journal:  BMC Med       Date:  2016-01-22       Impact factor: 8.775

10.  Antidepressant-like effects and cognitive enhancement of Schisandra chinensis in chronic unpredictable mild stress mice and its related mechanism.

Authors:  Tingxu Yan; Bosai He; Shutong Wan; Mengjie Xu; Huilin Yang; Feng Xiao; Kaishun Bi; Ying Jia
Journal:  Sci Rep       Date:  2017-07-31       Impact factor: 4.379
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.